Lipovaxin adjuvant technology – harnessing the immune system to design tomorrow's vaccines
Lipovaxin is a versatile platform designed to secure the attachment of recombinant proteins to the surface of liposome delivery particles.
The approach enables an ordered array of recombinant proteins to efficiently be displayed on the surface of liposomes.
The platform is particularly suited to the development of multivalent recombinant vaccines
The liposomes can be used off-the-shelf and require no chemical modification of either the liposomes or the protein.
Customised liposomes can also be prepared to carry an internal cargo as well as a surface bound load.
The platform has the potential to improve current dendritic cell vaccine therapies.